Managed Access Program in Bahrain
How the managed access program pathway operates in Bahrain.
About Managed Access Program
Manufacturer-operated access programs with structured eligibility and oversight.
How Managed Access Program works in Bahrain
Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.
Patients in Bahrain seeking access under Managed Access Program typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Bahrain
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.